Valuation : Aprogen Medicines Inc.

Market Cap 45.09B 33.64M 28.98M 27.44M 24.87M 46.66M 3.21B 46.9M 326M 125M 1.63B 126M 124M 5.17B P/E 2024
-3.44x
P/E 2025 -2.95x
Enterprise Value 182B 136M 117M 111M 101M 189M 12.98B 190M 1.32B 506M 6.61B 510M 499M 20.87B EV / Sales 2024
1.93x
EV / Sales 2025 2.99x
Free-Float
80.56%
Yield 2024 *
-
Yield 2025 -
09-03 Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
09-02 Aprogen Biologics Inc. announced that it expects to receive KRW 20.000001094 billion in funding from Aprogen Medicines Inc. CI
08-21 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding from Jade New Technology Association CI
08-14 Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-09 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding from Jade New Technology Association CI
07-26 Aprogen Biologics Inc. announced that it has received KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
07-23 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding CI
07-14 Aprogen Medicines to Raise 2 Billion Won Through Convertible Bond Issue MT
07-13 Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
07-13 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding CI
05-28 Aprogen Medicines Inc. announced that it has received KRW 10 billion in funding from N2Tech Co.,Ltd CI
05-20 APTN Inc. announced that it has received KRW 122.600000101 billion in funding from Aprogen, Inc., Aprogen Medicines Inc., Aprogen Pharma Inc. and other investors. CI
05-15 Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
1 day+1.50%
1 week-6.02%
Current month-13.25%
1 month-24.25%
3 months-38.48%
6 months-57.71%
Current year-80.58%
1 week 1,976
Extreme 1976
2,175
1 month 1,976
Extreme 1976
3,250
Current year 1,961
Extreme 1961
11,880
1 year 1,961
Extreme 1961
14,070
3 years 1,961
Extreme 1961
28,410
5 years 1,961
Extreme 1961
110,250
10 years 1,961
Extreme 1961
875,250
Manager TitleAgeSince
Chief Executive Officer 63 2017-12-26
Comptroller/Controller/Auditor 69 2018-03-27
Director TitleAgeSince
Director/Board Member 63 2022-11-28
Director/Board Member 64 2022-07-17
Director/Board Member 62 2023-10-12
Date Insider Type Main position Quantity % Market Cap. Importance
1/17/25 Others 7,673 0.0025% -
1/19/24 Free 101,429 0.0383%
1/19/24 Free 198,187 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
+1.50%-6.02%-81.74%-91.65% 33.64M
-2.04%+5.91%+142.24%+299.01% 14.25B
+0.80%-8.46%+5.83%+38.69% 13.79B
+2.05%-5.77%-35.90%+2.05% 4.39B
-2.94%+1.47%+42.82%+48.54% 3.29B
-2.48%+1.17%+81.24%+108.48% 2.75B
-4.69%+6.69%+92.81%+188.09% 1.69B
-2.01%-5.17%-25.22%-19.50% 1.02B
+1.03%-3.02%+15.34%+10.87% 948M
-3.88%+1.77%+45.34%+75.91% 846M
Average -1.27%-3.24%+28.27%+66.05% 4.3B
Weighted average by Cap. -0.88%-4.21%+58.01%+130.92%

Financials

2024 2025
Net sales 150B 112M 96.49M 91.36M 82.81M 155M 10.7B 156M 1.09B 417M 5.44B 421M 411M 17.2B 118B 88.01M 75.83M 71.8M 65.08M 122M 8.41B 123M 853M 328M 4.28B 331M 323M 13.52B
Net income -58.08B -43.33M -37.33M -35.35M -32.04M -60.11M -4.14B -60.41M -420M -161M -2.11B -163M -159M -6.65B -70.2B -52.37M -45.12M -42.73M -38.73M -72.65M -5B -73.02M -507M -195M -2.55B -197M -192M -8.04B
Net Debt 70.04B 52.25M 45.02M 42.63M 38.64M 72.49M 4.99B 72.85M 506M 195M 2.54B 196M 192M 8.03B 137B 102M 88.13M 83.44M 75.63M 142M 9.77B 143M 991M 381M 4.97B 384M 376M 15.71B
Logo Aprogen Medicines Inc.
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Employees
253
Date Price Change Volume
26-09-11 ₩2,030.00 +1.50% 144,847
26-09-10 ₩2,000.00 0.00% 100,910
26-09-09 ₩2,000.00 -1.23% 181,086
26-09-08 ₩2,025.00 -4.48% 267,972
26-09-07 ₩2,120.00 -1.85% 334,121
  1. Stock Market
  2. Stocks
  3. A007460 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!